Stock listing
SILO Stock Price, News, Filings & Events — Silo Pharma, Inc.
Selected listing: SILO · NASDAQ · USD · US
This page tracks Silo Pharma, Inc.'s SILO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SILO:NASDAQ. SILO:NASDAQ is the stock-level entry point for investors researching Silo Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Silo Pharma, Inc. is a public company traded under the ticker SILO in the American market. The company has a market capitalization of approximately $5.5 million. Silo Pharma focuses on developing innovative therapies to address various medical conditions.
- Ticker
- SILO:NASDAQ
- Asset type
- Stock
- Market cap
- $3.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Silo Pharma, Inc. SILO:NASDAQ stock context
This page tracks Silo Pharma, Inc.'s SILO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SILO:NASDAQ. SILO:NASDAQ is the stock-level entry point for investors researching Silo Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Silo Pharma, Inc. is a public company traded under the ticker SILO in the American market. The company has a market capitalization of approximately $5.5 million. Silo Pharma focuses on developing innovative therapies to address various medical conditions.
Latest news from Silo Pharma, Inc.
Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program
July 21, 2026
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform
July 14, 2026
Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
July 10, 2026
Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program
July 7, 2026
Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial
June 23, 2026
Research Silo Pharma, Inc.
Silo Pharma, Inc. investor report
Review AI stock analysis and investor report context for SILO:NASDAQ.
Silo Pharma, Inc. company profile
View the public company page for Silo Pharma, Inc. on 6ix.
Silo Pharma, Inc. news
Read company news and market updates connected to Silo Pharma, Inc..
Silo Pharma, Inc. investor events
Find investor webinars, events, and replay context for Silo Pharma, Inc..